cyclohexanol has been researched along with ADDH in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ago, Y; Fujita, K; Hiramatsu, N; Kawanai, T; Matsuda, T; Takuma, K; Umehara, M | 1 |
| Caballero, J; Omidian, H; Park, P | 1 |
| Vitiello, B | 1 |
| Akhondzadeh, S; Hazrati, N; Mohammadi, MR; Rezaie, F; Rezazadeh, SA; Tabrizi, M; Zarinara, AR | 1 |
| Filatova, EG; Latysheva, NV; Naprienko, MV | 1 |
| Amiri, S; Farhang, S; Ghoreishizadeh, MA; Malek, A; Mohammadzadeh, S | 1 |
| Berk, M; Freeman, RD; Ghanizadeh, A | 1 |
| Maidment, ID | 1 |
| Abali, O; Mukaddes, NM | 1 |
| Bertschy, G; Carminati, GG; Deriaz, N | 1 |
| Heerdink, ER; van Dijk, L; Volkers, AC | 1 |
| Aharonovich, E; Bisaga, A; Brooks, DJ; Garawi, F; Levin, FR; Mariani, J; Nunes, EV; Raby, W; Rubin, E | 1 |
| Demeter, CA; Findling, RL; Greenhill, LL; Kotler, LA; McNamara, NK; Myers, C; O'Riordan, MA; Reed, MD | 1 |
| Gormly, LJ; Pleak, RR | 1 |
| Biederman, J; Spencer, TJ; Wilens, TE | 1 |
| Findling, RL; Flannery, DJ; Manos, MJ; Schwartz, MA | 1 |
| Hedges, D; Reimherr, FW; Rogers, A; Strong, R; Wender, PH | 1 |
| Adler, LA; Devinsky, O; Kunz, M; Resnick, S | 1 |
| Smith, MN | 1 |
| Luh, J; Olvera, RL; Pliszka, SR; Tatum, R | 1 |
| Dogin, JW; Findling, RL | 1 |
| Hornig, M | 1 |
| Chong, Y; Harris, R; Kim, WJ | 1 |
| Ninan, PT | 1 |
| Brady, KT; Malcolm, R; Sethuraman, G; Sonne, SC; Upadhyaya, HP | 1 |
| Amsterdam, JD; Hornig-Rohan, M | 1 |
6 review(s) available for cyclohexanol and ADDH
| Article | Year |
|---|---|
Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
Topics: Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Duloxetine Hydrochloride; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2014 |
Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Methylphenidate; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
The use of antidepressants to treat attention deficit hyperactivity disorder in adults.
Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Cyclohexanols; Humans; Propylamines; Venlafaxine Hydrochloride | 2003 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Dopamine; Dopamine Antagonists; Epinephrine; Humans; Mental Disorders; Norepinephrine; Prevalence; Psychotropic Drugs; Serotonin; Venlafaxine Hydrochloride | 1998 |
Use of venlafaxine in other psychiatric disorders.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride | 2000 |
10 trial(s) available for cyclohexanol and ADDH
| Article | Year |
|---|---|
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Methylphenidate; Outpatients; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine-Related Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Faculty; Female; Humans; Male; Norepinephrine; Parents; Pilot Projects; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Venlafaxine Hydrochloride | 2007 |
Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Psychometrics; Research Design; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
Open-label trial of venlafaxine in adults with attention deficit disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interviews as Topic; Male; Parents; Psychiatric Status Rating Scales; Psychological Tests; Reaction Time; Venlafaxine Hydrochloride | 1996 |
Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.
Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Comorbidity; Cyclohexanols; Humans; Middle Aged; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
10 other study(ies) available for cyclohexanol and ADDH
| Article | Year |
|---|---|
Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Male; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors; Venlafaxine Hydrochloride | 2013 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
[New approaches to the treatment of chronic daily headache].
Topics: Adult; Aminopyridines; Analgesics; Attention Deficit Disorder with Hyperactivity; Constipation; Cyclohexanols; Diarrhea; Female; Headache Disorders; Humans; Male; Nausea; Pain Threshold; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Cyclohexanols; Female; Follow-Up Studies; Humans; Male; Self-Injurious Behavior; Time Factors; Venlafaxine Hydrochloride | 2006 |
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride | 2007 |
Effects of venlafaxine treatment for ADHD in a child.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Cyclohexanols; Female; Humans; Hypertension; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Venlafaxine for adult ADHD.
Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Pharmacologic properties of venlafaxine.
Topics: Adrenergic Uptake Inhibitors; Adult; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Dopamine Uptake Inhibitors; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Dystonia as a side effect of nonneuroleptics.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Drug Interactions; Dystonia; Fluoxetine; Guanfacine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride | 1999 |
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.
Topics: Adult; Aged; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Venlafaxine Hydrochloride | 2002 |